Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- Check2 days agoChange DetectedNo significant changes detected; the study details page content and layout remain consistent with its purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.4.2. The previous Revision: v3.4.1 and the government funding operating-status notice were removed.SummaryDifference0.2%

- Check16 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center status appears on the page, and a page revision tag shows Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded a glossary toggle and update-tracking labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data) with a new revision label (v3.4.0). Removed the older QC label, outdated No FEAR Act wording, and the previous revision (v3.3.4).SummaryDifference0.1%

- Check37 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no substantive changes to study content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page appears to contain the same sections and content as before, with only minor formatting changes. No additions or deletions to core study details such as objectives, eligibility, outcomes, or listed locations were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.